Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas

Nature Medicine

Volumn 9, Issue 6, 2003, Pages 774-780

  Doll, Jennifer A ^a   Stellmach, Veronica M ^a   Bouck, Noël P ^a   Bergh, Anders R J ^c   Lee, Chung ^a   Abramson, Lisa P ^b   Cornwell, Mona L ^a   Pins, Michael R ^a   Borensztajn, Jayme ^a   Crawford, Susan E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOGENESIS INHIBITOR; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANDROGEN RELEASE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TUMOR BIOPSY; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; AGED; ANDROGENS; ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; BLOOD VESSELS; CASTRATION; COBALT; EYE PROTEINS; HUMANS; HYPERPLASIA; IN SITU NICK-END LABELING; MALE; MICE; MICE, KNOCKOUT; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; PANCREAS; PROSTATE; PROSTATIC NEOPLASMS; PROTEINS; RATS; SERPINS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0038240367     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm870     Document Type: Article

References (45)

1. Bouck, N., Stellmach, V. & Hsu, S.C. How tumors become angiogenic. Adv. Cancer Res. 69, 135-174 (1996).
2. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
3. Folkman, J., Shochat, S.J., Strand, R.D. & Fellows, K.E. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186 (1971).
4. Franck-Lissbrant, I., Haggstrom, S., Damber, J.E. & Bergh, A. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats, Endocrinology 139, 451-456 (1998).
5. Shabsigh, A. et al. Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 36, 201-206 (1998).
6. Shabsigh, A. et al. Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology 140, 1920-1926 (1999).
7. Lekas, E., Johansson, M., Widmark, A., Bergh, A. & Damber, J.E. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration. Urol. Res. 25, 309-314 (1997).
8. Burchardt, M. et al, Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration. Prostate 43, 184-194 (2000).
9. Folkman, J. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology 139, 441-442 (1998).
10. Buttyan, R., Ghafar, M.A. & Shabsigh, A. The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression. Curr. Opin. Urol. 10, 415-420 (2000).
11. Shabsigh, A. et al. Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland. J. Cell. Biochem. 81, 437-444 (2001).
12. Pignolo, R.J., Rotenberg, M.O. & Cristofalo, V.J. Analysis of EPC-1 growth state-dependent expression, specificity, and conservation of related sequences. J. Cell. Physiol. 162, 110-118 (1995).
13. Tombran-Tink, J. et al. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vis. 2, 11-19 (1996).
14. Becerra, S.P. Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv. Exp. Med. Biol. 425, 223-237 (1997).
15. Dawson, D.W. et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285, 245-248 (1999).
16. Crawford, S.E. et al. Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell anti-tumor activity. J. Cell. Sci. 114, 4421-4428 (2001).
17. Taniwaki, T., Becerra, S. P., Chader, G.J. & Schwartz, J.P. Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J. Neurochem. 64, 2509-2517 (1995).
18. Bilak, M.M. et al. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J. Neuropathol. Exp. Neurol. 58, 719-728 (1999).
19. Cao, W. et al. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J. Neurosci. Res. 57, 789-800 (1999).
20. Tombran-Tink, J., Chader, G.G. & Johnson, L.V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53, 411-414 (1991).
21. Tombran-Tink, J. & Johnson, L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci. 30, 1700-1707 (1989).
22. Stellmach, V.V., Crawford, S.E., Zhou, W. & Bouck, N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Natl. Acad. Sci. USA 98, 2593-2597 (2001).
23. Bouck, N. PEDF: anti-angiogenic guardian of ocular function. Trends Mol. Med. 8, 330-334 (2002).
24. Iizumi, T., Yazaki, T., Kanoh, S., Kondo, I. & Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J. Urol. 137, 1304-1306 (1987).
25. van Bokhoven, A., Varella-Garcia, M., Korch, C, & Miller, G.J. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res. 61, 6340-6344 (2001).
26. Good, D.J. et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628 (1990).
27. Doll, J.A. et al. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 49, 293-305 (2001).
28. Joseph, I.B., Nelson, J.B., Denmeade, S.R. & Isaacs, J.T. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin. Cancer Res. 3, 2507-2511 (1997).
29. Jain, R.K. et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 95, 10820-10825 (1998).
30. Sordello, S., Bertrand, N. & Plouet, J. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochem. Biophys. Res. Commun. 251, 287-290 (1998).
31. Goldberg, M.A., Dunning, S.P. & Bunn, H.F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242, 1412-1415 (1988).
32. Lammert, E., Cleaver, O. & Melton, D. Induction of pancreatic differentiation by signals from blood vessels. Science 294, 564-567 (2001).
33. Matsumoto, K., Yoshitomi, H., Rossant, J. & Zaret, K.S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294, 559-563 (2001).
34. Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606-609 (1994).
35. Offield, M.F. et al, PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983-995 (1996).
36. Christofori, G., Naik, P. & Hanahan, D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol. Endocrinol. 9, 1760-1770 (1995).
37. Crawford, S.E. et al. Thrombospondin-1 is a major activator of TGF-b1 in vivo. Cell 93, 1159-1170 (1998).
38. Rupnick, M.A. et al. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. USA 99, 10730-10735 (2002).
39. Chung, L.W. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv. 23, 33-42 (1995).
40. Rowley, D.R. What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev. 17, 411-419 (1998).
41. Wong, Y.C. & Wang, Y.Z. Growth factors and epithelial-stromal interactions in prostate cancer development. Int. Rev. Cytol. 199, 65-116 (2000).
42. Cvetkovic, D. et al. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 57, 821-825 (2001).
43. Liu, X.H. et al. Upregulation of vascular endothelial growth factor by cobalt chloridesimulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastasis. 17, 687-694 (1999).
44. Semenza, G.L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35, 71-103 (2000).
45. Abramson, L.P. et al. Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J. Ped. Surg. 38, 336-342 (2003).